| Rebecca Claire Chiffer, MD | |
|
925 Chestnut St Fl 6, Philadelphia, PA 19107 | |
| (215) 955-6760 | |
| Not Available |
| Full Name | Rebecca Claire Chiffer |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 14 Years |
| Location | 925 Chestnut St Fl 6, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003134081 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thomas Jefferson University Hospital | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jefferson University Physicians | 7911819180 | 1269 |
News Archive
As the "recycling plant" of the cell, the proteasome regulates vitally important functions. When it is inhibited, the cell chokes on its own waste. Cancer cells, in particular, are very sensitive because they need the proteasome for their uncontrolled growth. Biochemists at the Technische Universitaet Muenchen (TUM) have now identified the lead structure of a new class of drugs that attacks the proteasome in an unusual way. New medication could be developed on the basis of this previously unknown binding mechanism.
A motor mechanism that has been attributed primarily to early development in babies and toddlers can also help older adults improve movement accuracy, according to new research from Ben-Gurion University of the Negev.
In its continuing initiatives around Doing What's Right, SC Johnson, A Family Company, recently announced its first commitment as part of its involvement in the Clinton Global Initiative (CGI). Founded by former President Bill Clinton in 2005, CGI brings world leaders from a variety of backgrounds together to create partnerships that result in innovative and measurable solutions to some of the world's most pressing challenges.
Oculus Innovative Sciences, Inc., a commercial medical technology company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that it has received new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new dermatology indications for Microcyn® Skin and Wound HydroGel.
› Verified 7 days ago
| Entity Name | Jefferson University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326093675 PECOS PAC ID: 7911819180 Enrollment ID: O20040225000232 |
News Archive
As the "recycling plant" of the cell, the proteasome regulates vitally important functions. When it is inhibited, the cell chokes on its own waste. Cancer cells, in particular, are very sensitive because they need the proteasome for their uncontrolled growth. Biochemists at the Technische Universitaet Muenchen (TUM) have now identified the lead structure of a new class of drugs that attacks the proteasome in an unusual way. New medication could be developed on the basis of this previously unknown binding mechanism.
A motor mechanism that has been attributed primarily to early development in babies and toddlers can also help older adults improve movement accuracy, according to new research from Ben-Gurion University of the Negev.
In its continuing initiatives around Doing What's Right, SC Johnson, A Family Company, recently announced its first commitment as part of its involvement in the Clinton Global Initiative (CGI). Founded by former President Bill Clinton in 2005, CGI brings world leaders from a variety of backgrounds together to create partnerships that result in innovative and measurable solutions to some of the world's most pressing challenges.
Oculus Innovative Sciences, Inc., a commercial medical technology company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that it has received new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new dermatology indications for Microcyn® Skin and Wound HydroGel.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Claire Chiffer, MD 925 Chestnut St Fl 6, Philadelphia, PA 19107-4204 Ph: (215) 955-6760 | Rebecca Claire Chiffer, MD 925 Chestnut St Fl 6, Philadelphia, PA 19107 Ph: (215) 955-6760 |
News Archive
As the "recycling plant" of the cell, the proteasome regulates vitally important functions. When it is inhibited, the cell chokes on its own waste. Cancer cells, in particular, are very sensitive because they need the proteasome for their uncontrolled growth. Biochemists at the Technische Universitaet Muenchen (TUM) have now identified the lead structure of a new class of drugs that attacks the proteasome in an unusual way. New medication could be developed on the basis of this previously unknown binding mechanism.
A motor mechanism that has been attributed primarily to early development in babies and toddlers can also help older adults improve movement accuracy, according to new research from Ben-Gurion University of the Negev.
In its continuing initiatives around Doing What's Right, SC Johnson, A Family Company, recently announced its first commitment as part of its involvement in the Clinton Global Initiative (CGI). Founded by former President Bill Clinton in 2005, CGI brings world leaders from a variety of backgrounds together to create partnerships that result in innovative and measurable solutions to some of the world's most pressing challenges.
Oculus Innovative Sciences, Inc., a commercial medical technology company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that it has received new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new dermatology indications for Microcyn® Skin and Wound HydroGel.
› Verified 7 days ago
Mark Rizzi, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 34th & Civic Center Blvd, Children's Hospital Of Philadelphia, Philadelphia, PA 19104 Phone: 215-590-3440 Fax: 215-590-3986 | |
Lukas David Dumberger, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 3400 Spruce St, Philadelphia, PA 19104 Phone: 215-662-2777 Fax: 215-662-4613 | |
Dr. Marc R. Rosen, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 925 Chestnut St, 6th Floor, Philadelphia, PA 19107 Phone: 215-955-6760 Fax: 215-923-4532 | |
Dr. Robert T Adelson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce Street, 5 Silverstein Building, Philadelphia, PA 19104 Phone: 215-662-2777 | |
Steven Bernard Cannady, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 800 Spruce St, Philadelphia, PA 19107 Phone: 215-829-5180 | |
Alexander G Chiu, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, 5 Silverstein Building, Philadelphia, PA 19104 Phone: 215-662-2777 Fax: 215-614-0071 |